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Purpose:  Prevention  is a  priority  in  the  ﬁght against  cancers,  especially  nutritional  prevention.  To  update
the  levels  of evidence  of  relationships  between  10 nutritional  factors  and  cancer  risk,  the  scientiﬁc
literature  published  from  2006  to 2014  was  reviewed  by an  expert  group.
Methods:  Data  from  133  meta-analyses,  pooled  analyses  or  intervention  trials  were  examined.  Nearly  150
relationships  between  nutritional  factors  and  cancer  at various  sites  were  evaluated.
Results:  According  to the  evidence  graded  as  convincing  or probable,  these  factors  were  divided  in two
groups.  Factors  which  increase  the  risk  of  cancer  are  alcoholic  beverages,  overweight  and  obesity,  red  meat
and  processed  meat,  salt and  salted  foods  and  beta-carotene  supplements.  Factors  which  decrease  the
risk of cancer  are  physical  activity,  fruits  and  vegetables,  dietary  ﬁber,  dairy  products  and  breastfeeding.
Conclusion:  Three  main  nutritional  objectives  should  be  attained  to improve  cancer  prevention:  to  reduce
alcoholic  beverages  consumption,  to have  a balanced  and  diversiﬁed  diet  and  to be physically  active.
© 2016  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is an open  access  article  under  the CC
BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
. Introduction
The worldwide burden of cancer has been estimated to 14
illion new cases for the year 2012, the most common cancers
iagnosed globally being those of the lung, breast, and large bowel.
his ﬁgure is expected to rise to 22 million per year within the next
wo decades (Ferlay et al., 2013). This alarming situation empha-
izes the need for urgent prevention measures to win the battle
gainst cancer (IARC, 2014a).
Prevention strategies must be based on a better evidence-based
nowledge of factors able to either increase or decrease cancer risk.
ancer is a multifactorial disease involving genetic, environmen-
al and behavioral factors, the latter including nutritional factors
hat comprise diet, alcohol consumption, body fatness and physi-
al activity. For more than two decades, the World Cancer Research
und (WCRF) and the American Institute for Cancer Research (AICR)
ave joined their efforts to summarize, assess and judge the evi-
ence on nutritional factors and the risk of various cancers. Since
heir report published in 2007 (WCRF/AICR, 2007), the WCRF/AICR
xpert panel keep updating the evidence for individual cancer sites,
ccording to the Continuous Update Project (CUP), in collabora-
ion with a team of the Imperial College of London (ICL) in charge
f systematic reviews and meta-analyses of epidemiological data,
ndependently of the expert panel’s judgement of the evidence.
In 2013, within the framework of the third Cancer Plan
2014–2019), the French National Institute of Cancer (INCa)
ecided to review the most recent scientiﬁc literature and update
he levels of evidence for the relationships between risk of cancers
nd nutritional factors. Ten nutritional factors were considered:
lcoholic beverages, overweight and obesity, red meat and pro-
essed meat, salt and salted foods, beta-carotene supplements,
hysical activity, fruits and vegetables, dietary ﬁber, dairy products,
reastfeeding. They were selected on the basis of the follow-
ng criteria: (i) relevant in terms of modiﬁable exposure for the
rench population and more generally for developed countries and
ii) level of evidence qualiﬁed as convincing or probable in the
007 WCRF/AICR report (WCRF/AICR, 2007) for at least one cancer
ite. For these factors, the levels of evidence have been evaluated
y WCRF/AICR in the 2007 main report (WCRF/AICR, 2007), and
010–2014 CUP reports on breast, colorectal, pancreatic, endome-
rial and ovarian cancers (WCRF/AICR, 2010, 2011, 2012, 2013,
014a). However, many epidemiological studies have been pub-
2. Methods
2.1. Evaluation process
From April 2013 to March 2015, INCa gathered an expert group
bringing together scientists from the French network on Nutrition
And Cancer Research (NACRe network), who have expertise in the
ﬁeld of nutrition and cancer. The modalities for the systematic lit-
erature review and evaluation of the evidence have been discussed
and adopted by the expert group. Notably, the nutritional factors
and types of studies to consider, the search strategies, and the selec-
tion criteria for publications have been deﬁned. The bibliographic
review was  divided among experts according to their respective
competences. The method of bibliography analysis, the nature of
data to extract from articles and the criteria for evaluating the lev-
els of evidence for the relationships between nutritional factors
and risk of cancers have been deﬁned by the expert group. They are
summarized in the next section.
2.2. Search strategy and selection criteria
Searches were conducted in PubMed database from January
2006 to February 2014, restricted to English language, by com-
bining medical subject headings (MeSH) and/or entry terms. Study
types were limited to meta-analyses, pooled analyses and interven-
tion trials. Search strategies for each of the 10 selected nutritional
factors are detailed in Appendix A, Part 1. For each nutritional fac-
tor, the title and abstract of all references provided by the search
were examined by one expert to select potential relevant full-text
articles, any uncertainties being resolved by discussion within the
expert group. Studies were selected if they met  the following inclu-
sion criteria: meta-analysis, pooled analysis or intervention trial,
association between one of the 10 selected nutritional factors and
cancer risk in adults, report of hazard ratio (HR), relative risk (RR) or
odds ratio (OR) and of their 95% conﬁdence interval (CI). Studies on
a speciﬁc cancer site were selected if their publication date was sub-
sequent to the more recent WCRF/AICR report (2007 main report
or CUP report on this cancer site) (WCRF/AICR, 2007, 2010, 2011,
2012, 2013, 2014a); publications from the ICL team were consid-
ered as new meta-analyses if they provided updated or additional
results as compared to those presented in the “systematic literature
review” reports associated to the main WCRF/AICR or CUP reportsished since then, requiring a reassessment of the levels of evidence. (WCRF/AICR, 2007, 2010, 2011, 2012, 2013, 2014a). The outcome
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hould be ﬁrst primary cancers, excluding preneoplastic lesions or
iomarkers, and mortality. Populations at high risk of cancer (e.g.,
ith Lynch syndrome, polycystic ovary syndrome or diabetes) were
xcluded.
.3. Data extraction
Using a standardized data collection form, each expert extracted
he following information from the full-text selected articles: for
ll studies, ﬁrst author’s last name, publication year, type of study,
opulations’ characteristics (sample size, mean age, gender), can-
er site, number of cases, groups’ comparison or dose-response
elationship and corresponding HRs, RRs or ORs, and 95% CIs,
eterogeneity, adjustment factors and bias; for meta-analyses or
ooled analyses: inclusion/exclusion criteria, number and type of
tudies included, mean follow-up for included cohort studies, coun-
ries in which the included studies were conducted, exposure,
djustment for covariates and stratiﬁcation; for meta-analyses:
ensitivity analyses; for intervention trials: name of the trial, coun-
ry in which the trial was conducted, randomization, blindness,
ntervention (type, duration), follow-up duration and number of
ubjects lost to follow-up. For each nutritional factor, a second
xpert independently double checked the extraction of primary
ata from every study. Discrepancies were solved through discus-
ion. All extracted data are available in French language on the INCa
ebsite (INCa, 2015a).
.4. Updating the evidence
The summary of extracted data and the updated level of evi-
ence proposed by each expert were reviewed independently by
 second expert and discussed by the overall expert group until a
onsensus was found. Finally, the levels of evidence were qualiﬁed
s convincing, probable, suggestive or not conclusive, according to
he criteria that were deﬁned (Table 1).
. Results
Fig. 1 shows the ﬂow chart of the study selection process. From
he 1959 abstracts provided by searches in Medline database, 262
otentially full text articles were identiﬁed and examined. Finally,
33 articles meeting the inclusion criteria and reporting usable
nformation were analyzed by the expert group. They include 108
eta-analyses, 20 pooled analyses, 4 intervention trials and one
ost-intervention study which relate to 26 cancer sites overall. Gen-
rally, in the studies included in meta-analyses or pooled analyses,
ge, gender and the main known confounding factors for the stud-
ed cancer site have been controlled for. In Tables 1–10 of Appendix
, Part 2, the main results from these studies and the updated lev-
ls of evidence are reported for the associations between the ten
utritional factors and cancer sites. In the following sections the
eﬁnition and indicators of each nutritional factor and the new
tudies identiﬁed are presented. Then, the results and conclusions
f the evaluation process by the expert group are summarized: for
ancers sites for which a convincing or probable level of evidence
s established, followed by those for which it is suggestive or not
onclusive, and ﬁnally plausible mechanisms when available.
.1. Alcoholic beverages
Alcoholic beverages include wines, beers, spirits, ciders and var-
ous other alcoholic drinks that may  be locally important. They
ontain ethanol which results from the process of fermentation.
n epidemiological studies, the exposure to alcoholic beverages
s examined by different measures: drinking or not, number of
rinks/glasses or units of 10 g alcohol per day or per week.cology/Hematology 99 (2016) 308–323
The associations between alcohol drinking and the risk of var-
ious cancers have been evaluated by WCRF/AICR in 2007 and
2010–2014 CUP reports (WCRF/AICR, 2007, 2010, 2011, 2012, 2013,
2014a). Since the publication of these reports, 25 meta-analyses
(Islami et al., 2010; Turati et al., 2010; Tramacere et al., 2010; Turati
et al., 2013a; Petti et al., 2013; Islami et al., 2011; Tramacere et al.,
2012a; Seitz et al., 2012; Song et al., 2012; Rota et al., 2012; Mao
et al., 2010; Pelucchi et al., 2012; Tramacere et al., 2012b,c,d; Li et al.,
2011a; Zhuo et al., 2012; Fang et al., 2011; Yang et al., 2010; Zhang
et al., 2010; Liu et al., 2011a; Liu et al., 2012a; Chao, 2007; Boccia
et al., 2009; Guo et al., 2012) and 12 pooled analyses were identi-
ﬁed (Hashibe et al., 2007; Hashibe et al., 2009; Purdue et al., 2009;
Freedman et al., 2011; Lubin et al., 2012; Lucenteforte et al., 2012;
Lee et al., 2007a; Kelemen et al., 2013; Boffetta et al., 2012; Kitahara
et al., 2012; Langevin et al., 2009; Shimazu et al., 2012) (Appendix
A, Part 2: Table 1). The association between alcohol drinking and
the incidence of 19 different cancer sites was  investigated. Among
the 37 new studies identiﬁed, 25 provided results on total alco-
hol drinking and cancer risk (Islami et al., 2010; Turati et al., 2010;
Tramacere et al., 2010; Turati et al., 2013a; Petti et al., 2013; Islami
et al., 2011; Tramacere et al., 2012a; Seitz et al., 2012; Song et al.,
2012; Rota et al., 2012; Mao  et al., 2010; Pelucchi et al., 2012;
Tramacere et al., 2012b,c,d; Hashibe et al., 2007; Hashibe et al.,
2009; Purdue et al., 2009; Freedman et al., 2011; Lubin et al., 2012;
Lucenteforte et al., 2012; Lee et al., 2007a; Kelemen et al., 2013;
Boffetta et al., 2012; Kitahara et al., 2012) and 12 focused on cer-
tain genetic polymorphisms (Zhuo et al., 2012; Fang et al., 2011;
Yang et al., 2010; Zhang et al., 2010; Liu et al., 2011a; Liu et al.,
2012a; Boccia et al., 2009; Guo et al., 2012; Langevin et al., 2009),
Asian populations (Li et al., 2011a; Shimazu et al., 2012) or speciﬁc
alcoholic beverages (Chao, 2007).
Overall, the associations between alcohol drinking and
increased risk of several cancers, previously evaluated and con-
sidered as “convincing” in the WCRF/AICR previous reports, are
strengthened by the results of recent publications. For the cancers
of the mouth, pharynx and larynx combined, the results of 6 recent
meta-analyses (Islami et al., 2010; Turati et al., 2010; Tramacere
et al., 2010; Turati et al., 2013a; Li et al., 2011a; Zhuo et al., 2012) and
3 pooled analyses (Hashibe et al., 2007; Hashibe et al., 2009; Purdue
et al., 2009) of observational studies conﬁrmed the association.
The increased risk of oesophageal cancer was observed in 2 recent
pooled analyses of observational studies (Freedman et al., 2011;
Lubin et al., 2012) and 2 meta-analyses, one including observational
studies (Li et al., 2011a) and one exclusively cohorts (Islami et al.,
2010). For breast cancer, the WCRF/AICR conclusion (WCRF/AICR,
2010) was  reinforced by a new meta-analysis of cohort studies
(Seitz et al., 2012). Concerning colorectal cancer associations con-
sidered as “convincing” in men  and “probable” in women, the level
of evidence was not changed since the only new meta-analysis
including exclusively 10 case-control studies conducted on Chinese
men  and women combined showed no signiﬁcant results (Li et al.,
2011a). The association with liver cancer, considered as “probable”
in the 2007 WCRF/AICR report (WCRF/AICR, 2007), was also con-
ﬁrmed by 2 meta-analyses (Li et al., 2011a; Liu et al., 2011a) and
one pooled analysis (Shimazu et al., 2012) of observational studies.
The increased risk of pancreatic cancer associated with con-
sumption of 3 drinks per day or more is conﬁrmed by the results
of a recent pooled analysis of 10 case-control studies (Lucenteforte
et al., 2012) though a non-signiﬁcant increased risk was observed
in the meta-analysis conducted on Chinese populations (Li et al.,
2011a). Thus, the corresponding level of evidence previously
judged as “suggestive” is unchanged.The new results available for other cancer sites—kidney (Song
et al., 2012; Lee et al., 2007a), lung (Li et al., 2011a; Chao, 2007),
prostate (Rota et al., 2012; Li et al., 2011a), bladder (Mao  et al., 2010;
Pelucchi et al., 2012; Li et al., 2011a), stomach (Tramacere et al.,
P. Latino-Martel et al. / Critical Reviews in Oncology/Hematology 99 (2016) 308–323 311
Table  1
Criteria used by the INCa expert group to conﬁrm or update the evidence.
Grade Criteria required Lacks or limits
Convincing Meta-analysis or pooled analysis of prospective studies with:
—Statistically signiﬁcant association
—Dose-response analysis
—High number of studies or cases
—No high and unexplained heterogeneity*
—Robustness of results in sensitivity analyses
—Intervention trial if possible
—Plausible mechanisms
Probable Meta-analysis or pooled analysis with:
—Statistically signiﬁcant association
—High number of studies or cases
—No high and unexplained heterogeneity*
—Plausible mechanisms
—Neither meta-analysis nor pooled analysis of prospective studies
OR
—No dose-response analysis
Suggestive Meta-analysis or pooled analysis with:
—Statistically signiﬁcant association
—Plausible mechanisms
—Neither meta-analysis nor pooled analysis of prospective studies
AND no dose-response
OR
—High unexplained or unspeciﬁed heterogeneity
Not  conclusive —Neither meta-analysis nor pooled analysis
OR
—No statistically signiﬁcant association from meta-analysis or pooled
analysis
OR
—Inconsistency between meta-analyses or pooled analyses
OR
—No  plausible mechanisms
Improbable Meta-analysis or pooled analysis of prospective studies with:
—No statistically signiﬁcant association
—Dose-response that is not statistically signiﬁcant
—High number of studies or cases
—No high and unexplained heterogeneity*
—Robustness of results in sensitivity analyses
—Intervention trial if possible
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1959 references idenﬁed in Medli ne
262 full-text arcles assessed for eligibility
133 arcles meeng inclusion criteria, with usable informaon:
108 arcles  corres pond ing to  meta-ana lyses  , 20 to  poo led ana lyses  
1697 references exclud ed by  review of the tle and  abstract
129 full-text arcles  exclud ed for irrelevant des ign,
outcome or exposure, for incomp lete data, or publi caon 
before the more recent WCRF/AI CR report    —No plausible mechanisms
* High heterogeneity: I2 ≥ 75% (WCRF/AICR, 2007).
012b; Li et al., 2011a) and ovary (Kelemen et al., 2013)—conﬁrm
he “not conclusive” level of evidence of the WCRF/AICR reports
WCRF/AICR, 2007, 2014a). Recent publications concerning cancer
ites which were not previously evaluated by WCRF/AICR—small
ntestine (Boffetta et al., 2012), Hodgkin and non-Hodgkin lym-
homa (Tramacere et al., 2012c, 2012d), Ampulla of Vater (Li et al.,
011a) and thyroid (Kitahara et al., 2012)—do not suggest any asso-
iation between the risk of these cancers and alcohol drinking. In
he absence of new data, the “not conclusive” level of evidence for
ndometrial cancer remains unchanged.
The mechanisms of alcoholic beverages-mediated carcinogen-
sis mainly involve the pro-carcinogenic effects of acetaldehyde,
he main metabolite of ethanol. Several other molecular and
hysiopathological effects have been identiﬁed: redox changes,
ormation of radicals, liver injury, elevation of sex hormones lev-
ls, folate deﬁciency, interaction with tobacco smoking etc (IARC,
012).
.2. Overweight and obesity
Body fatness which includes overweight and obesity is gener-
lly estimated by the body mass index (IMC) calculated by the
atio weight (kg)/height2 (m2). Abdominal fatness, estimated by the
aist measurement or the waist-to-hips ratio, is another indicator
sed to characterize corpulence.
The associations between overweight/obesity and the risk of
arious cancers have been evaluated by WCRF/AICR in 2007 and
010–2014 CUP reports (WCRF/AICR, 2007, 2010, 2011, 2012, 2013,
014a). Since the publication of the 2007 report, 24 new meta-
nalyses (Turati et al., 2013b; Aune et al., 2012a; Ma  et al., 2013;
heraghi et al., 2012; Amadou et al., 2013; Ildaphonse et al., 2009;and 5  to  intervenon tr ials 
Fig. 1. Flow chart of study selection.
Mathew et al., 2009; Chen et al., 2012a; Rui et al., 2012; Wang
et al., 2012; Discacciati et al., 2012; Willett et al., 2008; Larsson and
Wolk, 2011, 2008; Castillo et al., 2012; Wallin and Larsson, 2011;
Yang et al., 2009; Chen et al., 2013; Zhao et al., 2012; Lerro et al.,
2010; Olsen et al., 2008; Sergentanis et al., 2013; Yang et al., 2013a;
Gaudet et al., 2010) and one pooled analysis were identiﬁed (Hoyo
et al., 2012) (Appendix A, Part 2: Table 2). They cover a total of 17
different cancer sites.
The association between body fatness and the increased risk
of oesophagus adenocarcinoma, previously judged as “convinc-
ing” (WCRF/AICR, 2007). is conﬁrmed by recent results of both
a pooled analysis (Hoyo et al., 2012) and a meta-analysis (Turati
et al., 2013b) of observational studies. Since the WCRF/AICR 2012
report (WCRF/AICR, 2012), one recent meta-analysis of the ICL
team (Aune et al., 2012a) conﬁrms the increase of pancreas
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ancer risk associated with both body and abdominal fatness, and
he corresponding level of evidence judged as “convincing”. Consis-
ent with previous evaluations (WCRF/AICR, 2011), the associations
etween body/abdominal fatness and colorectal/colon/rectum can-
er with a level of evidence judged as “convincing”, are conﬁrmed
y one new meta-analysis of prospective studies (Ma  et al., 2013).
or breast cancer, 2007 and 2010 WCRF/AICR reports (WCRF/AICR,
007, 2010) emphasized the need for stratiﬁcation according to
he menopausal status. The increase of postmenopausal breast
ancer risk with body fatness which was judged as “convincing”,
s conﬁrmed by one new meta-analysis of observational studies
Cheraghi et al., 2012). In addition, the decrease of premenopausal
reast cancer risk with body fatness which was judged as “prob-
ble” considering the speculative mechanisms and the divergent
ata, is conﬁrmed by two new meta-analyses of observational
Cheraghi et al., 2012) and prospective (Amadou et al., 2013) stud-
es. The “convincing” level of evidence established in the 2013
CRF/AICR report (WCRF/AICR, 2013) for the increase of endome-
rial cancer risk associated with body fatness, weight gain in the
dulthood and abdominal fatness, is unchanged, since no new
tudy was identiﬁed. For kidney cancer, the level of evidence of
he increased risk associated with body fatness which was judged
s “convincing” (WCRF/AICR, 2007) is conﬁrmed by two meta-
nalyses of observational studies (Ildaphonse et al., 2009; Mathew
t al., 2009).
In the absence of new data, the level of evidence judged as
probable” for an increased risk of gallbladder and ovary can-
er associated with body fatness (WCRF/AICR, 2007) remains
nchanged. The evidence of the association between body fatness
nd the risk of liver cancer judged as “suggestive” (WCRF/AICR,
007), in the light of three new meta-analyses of prospective
tudies (Chen et al., 2012a; Rui et al., 2012; Wang et al., 2012),
s thereafter considered as “probable”. For prostate cancer, the
evel of evidence of the association between body fatness and the
ncreased risk was judged as “not conclusive” considering the het-
rogeneity of data (WCRF/AICR, 2007). In the light of one new
eta-analysis of 13 prospective studies (Discacciati et al., 2012),
he link between body/abdominal fatness and advanced prostate
ancer risk is strengthened and the level of evidence is deﬁned
s “probable”. For the localised prostate cancer, the “not con-
lusive” level of evidence remains unchanged in the absence of
lausible mechanisms. Concerning lymphoid and haemopoietic
ystem which were not previously evaluated by WCRF/AICR, recent
eta-analyses on non-Hodgkin (Willett et al., 2008; Larsson and
olk, 2011) and Hodgkin (Larsson and Wolk, 2011) lymphoma,
eukemia (Larsson and Wolk, 2008; Castillo et al., 2012), and multi-
le myeloma (Wallin and Larsson, 2011) suggest an increased risk
ssociated with body fatness (IMC) with a level of evidence judged
s “probable”.
For stomach, since the WCRF/AICR 2007 report (WCRF/AICR,
007), three new meta-analyses (Turati et al., 2013b; Yang et al.,
009; Chen et al., 2013) are in favor of an increased risk of proxi-
al  (cardia) gastric cancer in relation with body fatness. So the level
f evidence is thereafter deﬁned as “suggestive”. For distal (not car-
ia) gastric cancer the “not conclusive” level of evidence remains
nchanged. In the light of results of one new meta-analysis of 7
rospective studies (Zhao et al., 2012), the level of evidence of the
ssociation between body fatness and the increased risk of thy-
oid cancer is judged as “suggestive”. The new results available for
estis (Lerro et al., 2010) and skin (melanoma) (Olsen et al., 2008;
ergentanis et al., 2013) cancers do not suggest any association with
ody fatness. The levels of evidence of a decreased risk of lung (Yang
t al., 2013a) and mouth, pharynx, larynx cancers (Gaudet et al.,
010) associated with body fatness, are judged as “not conclusive”,
onsidering the lack of mechanistic justiﬁcation and the existence
f confounding factors not taken into account.cology/Hematology 99 (2016) 308–323
Some mechanisms seem common to all cancer sites: the excess
of intra-abdominal adipose tissue favors tissue insulinoresistance,
chronic hyperinsulinemia, increased production and activity of the
mitogenic factor insulin growth factor 1 (IGF-1), estrogen produc-
tion via the aromatase activity, chronic low-grade inﬂammation
resulting from the production of pro-inﬂammatory factors i.e.,
tumor-necrosis factor- (TNF), interleukin (IL-6), and adipokins,
and oxidative stress due to lipid peroxidation production (Calle
and Kaaks, 2004). Other mechanisms are speciﬁc to certain cancer
sites: for oesophagus, gastro-oesophageal reﬂux favoring lesions of
the oesophageal epithelium and cardia; for postmenopausal breast
and endometrial cancer, increased proliferation-effect of estrogens
via their estrogen receptor expression; for kidney, development
of a high blood pressure leading to an increase of the glomeru-
lar ﬁltration and thus the risk of renal damage, and alterations of
the cholesterol metabolism; for gallbladder, increased formation
of gallstones, probably by an over-saturation of the bile in choles-
terol; for liver: development of a steatosis with a local inﬂammation
through an oxidative stress and a greater risk of ﬁbrosis and car-
cinogenesis; for prostate, a reduced production of testosterone, an
important factor in the differentiation of the prostatic epithelium;
for haemopoietic system, local inﬂammation of the bone marrow
microenvironment activating T cells and macrophages (Askmyr
et al., 2011; Meijer et al., 2011).
3.3. Red and processed meat
Red meat comprises all ﬂesh from domesticated animals that
have more red than white muscle ﬁbers. In epidemiological studies,
it refers to beef, pork, lamb and goat. Processed meat refers to meats
preserved by smoking, curing or salting or addition of chemical
preservatives.
The associations between the intakes of red and processed meat
and the risk of various cancers have been evaluated by WCRF/AICR
in 2007 and 2010–2014 CUP reports (WCRF/AICR, 2007, 2010, 2011,
2012, 2013, 2014a). Since the publication of these reports, 15 new
meta-analyses (Chan et al., 2011; Alexander et al., 2011; Larsson
and Wolk, 2012; Paluszkiewicz et al., 2012; D’Elia et al., 2012; Yang
et al., 2012; Choi et al., 2013; Huang et al., 2013; Salehi et al., 2013;
Wang and Jiang, 2012; Taylor et al., 2009; Alexander et al., 2010a;
Alexander and Cushing, 2009; Faramawi et al., 2007; Alexander
et al., 2010b) and one pooled analysis (Lee et al., 2008) were iden-
tiﬁed (Appendix A, Part 2: Table 3). They cover a total of 9 different
cancer sites. Twelve studies concern both red and processed meat
(Chan et al., 2011; Alexander et al., 2011; Larsson and Wolk, 2012;
Yang et al., 2012; Choi et al., 2013; Huang et al., 2013; Salehi et al.,
2013; Wang and Jiang, 2012; Alexander et al., 2010a; Faramawi
et al., 2007; Alexander et al., 2010b; Lee et al., 2008), three focus on
red meat (Alexander et al., 2011; Paluszkiewicz et al., 2012; Taylor
et al., 2009) and one on processed meat (D’Elia et al., 2012).
The “convincing” level of evidence of the association between
red and processed meat and the increase of colorectal cancer risk
established in the 2011 WCRF/AICR report (WCRF/AICR, 2011), is
conﬁrmed by results of recent meta-analyses of cohort studies
(Chan et al., 2011; Alexander et al., 2011).
Based on results of two  recent meta-analyses (Larsson and Wolk,
2012; Paluszkiewicz et al., 2012), the level of evidence previously
judged as “suggestive” (WCRF/AICR, 2007) for increased risk of
pancreas cancer associated with red and processed meat remains
unchanged. The level of evidence also previously judged as “sug-
gestive” for the increased risk of stomach cancer with processed
meat and for the increased risk of lung cancer with red meat is
conﬁrmed by the recent results of respectively one meta-analysis
including seven cohorts (D’Elia et al., 2012) and one meta-analysis
of 18 observational studies (Yang et al., 2012).
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In the light of results of three new meta-analyses (Choi et al.,
013; Huang et al., 2013; Salehi et al., 2013), the level of evidence
f the association between the risk of oesophagus cancer and red
nd processed meat previously judged as “suggestive” (WCRF/AICR,
007) is thereafter considered as “not conclusive”. The association
etween the increase of lung and prostate cancers with processed
eat previously judged as “suggestive” (WCRF/AICR, 2007) is not
onﬁrmed respectively by a new meta-analysis of 10 observa-
ional studies (Yang et al., 2012) and by a new meta-analysis of 15
rospective studies (Alexander et al., 2010b). Therefore, the level
f evidence is judged as “not conclusive”.
Recent publications investigated the associations between red
nd processed meat and bladder, breast and kidney cancers and
etween red meat and prostate cancer, which were not previously
valuated by WCRF/AICR. The new results available for bladder
Wang and Jiang, 2012) and breast (Taylor et al., 2009; Alexander
t al., 2010a) suggest an association between the increased risk of
hese cancers and the consumption of red meat, and the level of
vidence is judged as “suggestive”. Considering the heterogeneity
f results between meta-analyses or the limited number of stud-
es, the level of evidence is considered “not conclusive” for kidney
ancer and red and processed meat (Alexander and Cushing, 2009;
aramawi et al., 2007; Lee et al., 2008), and for bladder (Wang and
iang, 2012) and breast (Alexander et al., 2010a) cancers and pro-
essed meat, and for prostate cancer and red meat (Alexander et al.,
010b). In addition, the evidence for endometrial (WCRF/AICR,
013) and ovarian (WCRF/AICR, 2014a) cancers for which no new
tudy was identiﬁed, remains “not conclusive”.
The mechanisms explaining the association of red and processed
eat consumption with an increased risk of cancer in several sites
re not clearly deﬁned. The effect on cancers may  be linked to muta-
enic compounds such as neoformed products generated in red
eats and processed meat: heterocyclic amines (HCA), polycyclic
romatic hydrocarbons (PAHs) and N-nitroso compounds (NOC)
Abid et al., 2014). For colon cancer, in addition to those assump-
ions, excess of heme iron has been proposed to play a central
ole. For processed meats, nitrates and nitrites used during pro-
ess may  represent an important part of the carcinogenic effect via
acilitation of NOC formation (Bastide et al., 2011).
.4. Salt and salted foods
According to epidemiological studies, the general term “salt”
omprises total salt consumption, including salt added during
ooking and at table but also salt from processed foods, including
alty and salted foods.
Since the evaluation of the association between the intake of salt
nd the risk of stomach cancer by WCRF/AICR in 2007 (WCRF/AICR,
007), only one new meta-analysis of 7 cohort studies was  identi-
ed (D’Elia et al., 2012) (Appendix A, Part 2: Table 4). The “probable”
evel of evidence of the increased risk of stomach cancer proposed
s thus conﬁrmed.
Several mechanisms involved in the tumor promoting effect of
alt on stomach cancer risk have been proposed. High dietary salt
ntake may  (i) facilitate the colonization of H. pylori, a risk factor for
tomach cancer, (ii) change the mucous viscosity and thus aggra-
ate exposure to N-nitroso compounds, known as carcinogens, and
iii) cause inﬂammatory responses of the gastric epithelium, with
n increased epithelial cell proliferation and so an increased risk of
ndogenous mutations (Wang and Jiang, 2012).
.5. Beta-carotene supplementsBeta-carotene is a pigment from the carotenoid family and a
recursor to vitamin A. It enters in the composition of many food
upplements, as deﬁned by the European Directive 2002/46/CE.cology/Hematology 99 (2016) 308–323 313
The associations between the intake of beta-carotene supple-
ments and the risk of various cancers have been evaluated by
WCRF/AICR in 2007 and 2010–2014 CUP reports (WCRF/AICR, 2007,
2010, 2011, 2012, 2014a). Since the publication of these reports, 17
new studies were identiﬁed: 11 meta-analyses (Aune et al., 2012e;
Jeon et al., 2011; Papaioannou et al., 2011; Stratton and Godwin,
2011; Cooper et al., 2010; Druesne-Pecollo et al., 2010; Jiang et al.,
2010; Bardia et al., 2008; Gallicchio et al., 2008; Tanvetyanon and
Bepler, 2008; Bjelakovic et al., 2008), one pooled analysis (Li et al.,
2012), 4 intervention trials (Lin et al., 2009; Neuhouser et al., 2009;
Hercberg et al., 2007; Wright et al., 2007) and one post-intervention
study (Ezzedine et al., 2010) (Appendix A, Part 2, Table 5). They
cover a total of 15 different cancer sites.
The evidence of the association between the intake of beta-
carotene supplements (high doses: ≥20 mg/d) and increased lung
cancer risk in smokers and subjects exposed to asbestos was pre-
viously evaluated in the 2007 WCRF/AICR report as “convincing”
(WCRF/AICR, 2007). This direct association is conﬁrmed by three
recent meta-analyses of intervention trials, especially in smokers
and subjects exposed to asbestos (Druesne-Pecollo et al., 2010;
Bardia et al., 2008; Tanvetyanon and Bepler, 2008). Two  other
meta-analyses of intervention trials in the general population (Jeon
et al., 2011; Gallicchio et al., 2008) observed no association. No
level of evidence was provided in the 2007 WCRF/AICR report
(WCRF/AICR, 2007) regarding the association between the intake
of beta-carotene supplements and stomach cancer risk. Based on a
meta-analysis of 7 intervention trials observing an increased risk
in all subjects for doses ≥20 mg/d and in smokers and subjects
exposed to asbestos (Druesne-Pecollo et al., 2010), the increased
risk at high doses (≥20 mg/d), especially for smokers and subjects
exposed to asbestos, is thus considered as “probable”.
The new results (meta-analyses and intervention trials) avail-
able for other cancer sites (detailed in Appendix A, Part 2: Table
5)—breast (Aune et al., 2012e; Druesne-Pecollo et al., 2010),
prostate (Stratton and Godwin, 2011; Druesne-Pecollo et al., 2010;
Jiang et al., 2010; Neuhouser et al., 2009), skin (melanoma and non-
melanoma) (Druesne-Pecollo et al., 2010; Hercberg et al., 2007;
Ezzedine et al., 2010), pancreas (Druesne-Pecollo et al., 2010;
Bjelakovic et al., 2008), colon and rectum (Papaioannou et al., 2011;
Cooper et al., 2010; Druesne-Pecollo et al., 2010; Bjelakovic et al.,
2008), bladder (Bardia et al., 2008), oesophagus (Bjelakovic et al.,
2008; Wright et al., 2007), ovary (Lin et al., 2009), mouth/pharynx
(Wright et al., 2007), larynx (Wright et al., 2007), uterus (Lin et al.,
2009), non-Hodgkin lymphoma (Lin et al., 2009) and head and neck
(Li et al., 2012)—were not sufﬁcient to draw conclusions regard-
ing their association with beta-carotene supplement use, thus, the
evidence remains “not conclusive”. Similarly, the evidence for kid-
ney cancer, for which no new study was  identiﬁed, remains “not
conclusive”.
Some mechanisms may  be suggested to explain the adverse
effect of beta-carotene supplementation on cancer risk, especially
in interaction with cigarette smoking. Direct contact of cigarette
smoke with tissues of some organs such as lung or stomach may
explain why these two cancer sites may  be more susceptible to
beta-carotene effect. For instance, high doses of beta-carotene may
exert a pro-oxidative effect: increased activation of carcinogenic
molecules released during smoking (activation of phase I enzymes
of the xenobiotic metabolism, such as cytochromes P450) result-
ing in the release of free radicals (Paolini et al., 2003) which, when
combined to the ones produced by cigarette smoking, may  lead
to their cleavage into unstable compounds that could intervene in
the oxidative process. Next, experimental models also suggest that
low doses of beta-carotene may  be protective against the alteration
of the tumor suppressive gene P53 caused by cigarette smok-
ing, whereas high doses may  promote these alterations. Besides,
when combined to cigarette smoke condensate, beta-carotene may
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ontribute to reduce the expression of a response protein to cellu-
ar stress (heme oxygenase 1), thereby decreasing the production
f anti-proliferation agents (Brambilla et al., 2008).
.6. Physical activity
Physical activity is deﬁned as any bodily movement produced
y skeletal muscle contraction resulting in increased energy expen-
iture above the resting energy expenditure. Physical activity in
he broad sense includes all movements performed in daily life
nd cannot be reduced only to sport, whether recreational or com-
etitive (WHO, 2010). It is generally expressed by its intensity in
etabolic equivalent of task (MET), given that one MET  refers by
onvention to the energy expenditure of an individual at rest, sit-
ing (estimated at about one kcal per kg of body weight per hour).
he intensity of a person’s physical activity expressed in MET  cor-
esponds to the ratio of their working metabolic rate (i.e., rate of
nergy consumption) to their resting metabolic rate. Thus, differ-
nt intensities of physical activity are deﬁned (Norton et al., 2010):
ery light intensity (or sedentary): 1–1.5 METs; light intensity: 1.6
o less than 3 METs; moderate intensity: 3 to less than 6 METs;
igorous intensity: 6 METs or more. In epidemiological studies,
hysical activity is computed by combining intensity, duration and
requency of different types of physical activity. Corresponding
otal energy expenditure is frequently expressed in MET.h/week.
ccording to their physical activity proﬁle, subjects are classiﬁed
nto three levels of physical activity, “low”, “moderate” or “high”.
hysical activity is conventionally divided into four types: occu-
ational, transport, recreational and household settings. Studies
resent “total physical activity,c¨alculated overall as the sum of the
our types, or any of the four types that are presented as all-type
hysical activity. Thus, a major barrier to conducting meta-analyses
s the disparity between physical activity measures.
The associations between physical activity and the risk of var-
ous cancers have been evaluated by WCRF/AICR in 2007 and in
010–2014 CUP reports (WCRF/AICR, 2007, 2010, 2011, 2012, 2013,
014a). Since their publication, seven new meta-analyses (Boyle
t al., 2012; Wu  et al., 2013a; Sun et al., 2012; Liu et al., 2011b;
ehrens and Leitzmann, 2013; Schmid et al., 2013; Vermaete et al.,
013) and one new pooled analysis (Nicolotti et al., 2011) were
dentiﬁed that cover a total of eight different cancer sites: head and
eck, colon, lymphoma, lung, prostate, kidney, breast and thyroid
Appendix A, Part 2: Table 6).
The association between physical activity and the decrease of
olon cancer risk, previously evaluated in the CUP WCRF/AICR 2011
eport with a level of evidence judged as ‘convincing’ (WCRF/AICR,
011), is conﬁrmed by results of a recent meta-analysis of prospec-
ive studies evaluating all-type physical activity (Boyle et al., 2012);
he protective effect was similar for proximal and distal colon
ancer, and was stronger for men  than for women. The associ-
tion with the risk of postmenopausal breast cancer, previously
valuated in the CUP WCRF/AICR 2010 report with a level of evi-
ence judged as “probable” (WCRF/AICR, 2010), is conﬁrmed by
esults of a recent meta-analysis of prospective studies evaluat-
ng all-type physical activity (Wu  et al., 2013a). The decreased risk
f premenopausal breast cancer associated with physical activity,
udged as ”suggested” by the WRCF/AICR 2007 report (WCRF/AICR,
007), is conﬁrmed by a recent meta-analysis of prospective studies
Wu et al., 2013a) and the evidence is now considered as “proba-
le”. Since the CUP WCRF/AICR 2013 report where the decrease
n endometrial cancer risk associated with physical activity was
udged as “probable” (WCRF/AICR, 2013), no new study was iden-
iﬁed. The decreased risk of lung cancer associated with physical
ctivity, judged as “suggested” by the WCFR/AICR 2007 report, was
onﬁrmed by a recent meta-analysis of prospective studies (Sun
t al., 2012). The risk reduction was even stronger for the highestcology/Hematology 99 (2016) 308–323
than for moderate physical activity level, compared to the lowest
level, with a level of evidence now judged as “probable”.
New results available since the publication of WCRF/AICR
reports for the risk of cancers of the prostate (Liu et al., 2011b), kid-
ney (Behrens and Leitzmann, 2013), head and neck (Nicolotti et al.,
2011) and thyroid (Schmid et al., 2013) and the risk of lymphoma
(Vermaete et al., 2013) suggest a level of evidence qualiﬁed as “not
conclusive”. No recent result was  available to reassess the level
of evidence judged as “not conclusive” in the WCRF/AICR reports
for the association between physical activity and the risk of rectal,
ovarian and pancreatic cancers (WCRF/AICR, 2007, 2013, 2014a).
The main mechanisms that could explain the beneﬁcial effect of
physical activity on cancer risk are related to its direct effects on
circulating levels of various hormones and growth factors, includ-
ing decreased plasma levels of estrogens, insulin and IGF-1 that
increase with overweight and obesity and promote cell prolifer-
ation (McTiernan, 2008). Physical activity may also lower cancer
risk by improving sensitivity to insulin, by stimulating immunity
and by decreasing adipokine levels, oxidative stress and inﬂam-
matory markers (Wu  et al., 2013a). Physical activity also indirectly
contributes to cancer risk reduction by decreasing the risk of over-
weight or obesity, limiting fat and promoting lean body mass.
Physical activity may  speciﬁcally lower the risk of colon cancer
through the acceleration of gut transit, reducing the exposure time
of the digestive mucosa to foodborne carcinogens. It may also lower
lung cancer risk by reducing the concentrations and interactions
of carcinogens with lung tissue through improved lung function
(Tardon et al., 2005; Buffart et al., 2014).
3.7. Fruits and vegetables
Fruits and vegetables comprise fresh, frozen, canned, raw and
cooked fruits and vegetables, excluding nuts, seeds, dried fruits,
potatoes and pulses (WCRF/AICR, 2007). According to epidemio-
logical studies, the general term “vegetables” may  cover different
categories: total vegetables (non-starchy vegetables and starchy
vegetables), non-starchy vegetables, fresh vegetables (as opposed
to preserved vegetables) and raw vegetables (excluding cooked
vegetables).
The associations between the intakes of fruits and (non-starchy)
vegetables and the risk of various cancers have been evaluated
by WCRF/AICR in 2007 and 2010–2014 CUP reports (WCRF/AICR,
2007, 2010, 2011, 2012, 2013, 2014a). Since the publication
of these reports, 17 studies were identiﬁed: 14 meta-analyses
(Soerjomataram et al., 2010; Liu et al., 2013a; Kim et al., 2010; Zhou
et al., 2011; Aune et al., 2012b; Wu  et al., 2013c, 2013b; Liu and Lv,
2013; Liu et al., 2013c; Chen et al., 2012b; Liu et al., 2012b; Liu et al.,
2013b; Wu  et al., 2013d; Yang et al., 2013b) and 3 pooled analyses
(Jung et al., 2013; Koushik et al., 2012; Lee et al., 2009) (Appendix
A, Part 2: Table 7). They cover a total of 10 different cancer sites.
Seven meta-analyses focus on fruits and vegetables alone or in com-
bination (Soerjomataram et al., 2010; Liu et al., 2013a; Kim et al.,
2010; Aune et al., 2012b; Jung et al., 2013; Koushik et al., 2012; Lee
et al., 2009) and others study more speciﬁcally certain subgroups of
vegetables: cruciferous vegetables (Wu  et al., 2013c,b; Liu and Lv,
2013; Liu et al., 2013c, 2012b, 2013b; Wu  et al., 2013d), tomatoes
(Chen et al., 2012b; Yang et al., 2013b), and allium vegetables (Zhou
et al., 2011).
The associations between fruits and (non-starchy) vegetables
and the decrease of the risk of cancers of the mouth, pharynx and
larynx combined, previously evaluated in the 2007 WCRF/AICR
report (WCRF/AICR, 2007), are conﬁrmed by results of a recent
meta-analysis of observational studies (Soerjomataram et al.,
2010). Consistent with previous evaluations (WCRF/AICR, 2007),
the association between fruits and vegetables and oesophagus can-
cer is conﬁrmed by two  new meta-analyses of observational studies
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Soerjomataram et al., 2010; Liu et al., 2013a). The association
ith stomach cancer is conﬁrmed for fruits by one meta-analysis
Soerjomataram et al., 2010), for vegetables by two  meta-analyses
Soerjomataram et al., 2010; Kim et al., 2010) and for allium vegeta-
les by one meta-analysis (Zhou et al., 2011). The decrease of lung
ancer associated with fruits is conﬁrmed by one meta-analysis
Soerjomataram et al., 2010). Since the 2011 WCRF/AICR report
WCRF/AICR, 2011), where the decrease of colorectal cancer risk
ssociated with garlic was judged as “probable”, no new study
as identiﬁed. For breast cancer, whereas a recent meta-analysis
howed no signiﬁcant association between total breast cancer risk
nd vegetables (Aune et al., 2012b), consistent with the 2010
CRF/AICR report evaluation (WCRF/AICR, 2010), a recent pooled
nalysis including 20 cohort studies showed a reduction of the risk
f estrogen receptor-negative (ER-) breast cancer associated with
on-starchy vegetables (Jung et al., 2013). Overall, with a level of
vidence judged as “probable”, these results conﬁrm the decrease
f risks of cancers of the mouth, pharynx, larynx, oesophagus, and
tomach associated with the consumption of fruits and vegetables,
he decrease in lung cancer risk associated with the consumption
f fruits and the decrease in colorectal cancer risk associated with
he consumption of garlic; they indicate a decreased risk of (ER-)
reast cancer associated with the consumption of vegetables.
With a level of evidence judged as “suggestive”, other new
tudies conﬁrm a decrease in lung cancer risk associated with con-
umption of vegetables (Soerjomataram et al., 2010); they indicate
 decreased risk of lung (Wu et al., 2013c), colorectal (Wu  et al.,
013b) and breast (Liu and Lv, 2013) cancer associated with the
onsumption of cruciferous vegetables. In the absence of new data,
he “suggestive” level of evidence for decreased risk of colorectal
nd nasopharynx cancer associated with the consumption of fruits
nd vegetables remains unchanged.
The new results available for other cancer sites—pancreas
Koushik et al., 2012), kidney (Liu et al., 2013c; Lee et al., 2009),
rostate (Chen et al., 2012b; Liu et al., 2012b), bladder (Liu et al.,
013b) and ER+ breast for non-starchy vegetables (Aune et al.,
012b; Jung et al., 2013)—do not suggest any association between
he risk of these cancers and the consumption of fruits and vegeta-
les. In addition, the evidence for cervical, endometrial, ovarian,
nd total breast cancers, for which no new studies were identiﬁed,
emains “not conclusive”.
Fruits and vegetables contain a great diversity of components
hich can exert protective properties against various cancers. Their
icroconstituents like polyphenols, carotenoids and sulfur com-
ounds have antioxidant and antiproliferative activities, and they
odulate xenobiotic and hormonal metabolism, and immunity
Liu, 2013a; Liu, 2013b). Fruits and vegetables are an important
ource of micronutrients, notably folates (vitamin B9) which play
n important role in DNA synthesis and methylation and in the
xpression of genes involved in carcinogenesis (Crider et al., 2012).
hey also contain ﬁbers that may  exert various protective effects
see next paragraph). More speciﬁcally, concerning ER- breast
ancer, oestrogen-independent mechanisms have been proposed:
eduction of proliferative factors like IGF-1 and cyclin E, and of
uclear transcription factor NF-kappaB involved in the immune
esponse (Jung et al., 2013).
.8. Dietary ﬁber
Dietary ﬁber refers to carbohydrate polymers (degree of poly-
erization: DP ≥3) of plant origin that may  or may  not be associatedn the plant to lignin or other non-carbohydrate compounds
polyphenols, waxes, saponins, cutin, phytates, phytosterols. . .),
nd to modiﬁed (physically, enzymatically or chemically) or syn-
hetic carbohydrate polymers.cology/Hematology 99 (2016) 308–323 315
The associations between dietary ﬁber intake and the risk of
various cancers have been evaluated by WCRF/AICR in 2007 and
2010–2014 CUP reports (WCRF/AICR, 2007, 2010, 2011, 2012, 2013,
2014a). Since the publication of these reports, 3 new meta-analyses
were identiﬁed (Aune et al., 2012c; Coleman et al., 2013; Zhang
et al., 2013) (Appendix A, Part 2: Table 8). They cover 3 differ-
ent cancer sites. Two meta-analyses (Aune et al., 2012c; Zhang
et al., 2013) considered different types (soluble and insoluble) and
sources (fruits, vegetables and cereals) of dietary ﬁber.
Since the 2011 WCRF/AICR report (WCRF/AICR, 2011), where
the decrease of colorectal cancer risk associated with dietary ﬁber
intake was judged as “convincing”, no new study was  identiﬁed.
The association between breast cancer risk and dietary ﬁber intake
previously judged as “not conclusive” in the 2010 WCRF/AICR
report (WCRF/AICR, 2010) was strengthened by one new meta-
analysis of 16 prospective studies (Aune et al., 2012c) showing a
decreased risk, especially observed for soluble ﬁber intake, and for
total dietary ﬁber intake ≥25 g/d. These new results were consid-
ered as sufﬁcient to increase the level of evidence to a “probable”
decreased risk of breast cancer associated with dietary ﬁber intake.
One new meta-analysis (8 case-control studies) conﬁrms a
decrease in oesophagus cancer risk associated with dietary ﬁber
intake (Coleman et al., 2013), with a level of evidence judged as
“suggestive”. A new meta-analysis (2 cohorts and 19 case-control
studies) (Zhang et al., 2013) suggested a decreased stomach can-
cer risk associated with dietary ﬁber intake (insoluble and soluble
and from fruits, vegetables or cereals). However, since the results
from the two  included prospective studies were non-signiﬁcant,
the level of evidence remains “not conclusive”. In addition, the evi-
dence for endometrium, ovary, pancreas, mouth, larynx, pharynx,
lung and prostate cancers, for which no new study was  identiﬁed,
remains “not conclusive”.
Dietary ﬁbers are not digested or absorbed in the small intestine.
They show at least one of the following physiological properties:
increased stool bulk, increased fermentation by colonic micro-
biota, reduced fasting blood cholesterol, reduced post-prandial
blood glucose and/or insulin. Dietary ﬁbers may  exert a protective
effect in the development of several cancers through prevention
of insulin-resistance, decrease in IGF-1 activity, decrease in sys-
temic inﬂammation via the production of short-chain fatty acids
(SCFA) by gut microbiota, and optimization of the colonic micro-
biota reinforcing the intestinal barrier (Probst-Hensch et al., 2003;
Canani et al., 2011; Kaczmarczyk et al., 2012). Dietary ﬁber may also
have a speciﬁc protective role against hormone-dependent cancer
(i.e., breast cancer) through the reduction of circulating steroid hor-
mones concentration (Moore et al., 1998; Longcope et al., 2000).
Finally, the decreased colorectal cancer risk is supported by a local
action of dietary ﬁbers in the colon: increased stool bulk and dilu-
tion of carcinogens through water binding, decreased intestinal
transit time, binding to carcinogens and secondary biliary acids
and production of SCFA with anti-proliferative and pro-apoptosis
properties (Moore et al., 1998).
3.9. Dairy products
Dairy products generally comprise milk (whole or skim milk),
cheese (fresh, cottage and hard cheese), and yoghurt. Some rare
studies also include butter or ice cream (Huncharek et al., 2008).
The associations between dairy products consumption and the
risk of various cancers have been evaluated by WCRF/AICR in 2007
and 2010–2014CUP reports (WCRF/AICR, 2007, 2010, 2011, 2012,
2013, 2014a). Since the publication of these reports, 7 new meta-
analyses were identiﬁed (Huncharek et al., 2008; Aune et al., 2012d;
Qin et al., 2007; Li et al., 2011b; Mao  et al., 2011; Dong et al., 2011;
Lee et al., 2007b) (Appendix A, Part 2: Table 9). They cover 5 dif-
ferent cancer sites. Most of these studies considered total dairy
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Table  2
Nutritional factors either increasing or reducing the risk of cancer with a convincing or probable level of evidence, as updated by the INCa expert group.
Nutritional factors increasing cancer risk Cancer sites Nutritional factors
reducing cancer risk
Cancer sites
Alcoholic beverages Mouth
Pharynx
Larynx
Œsophagus
Colon and rectum
Liver
Breast
Physical activity Colon
Lung
Breast
Endometrium
Overweight and obesity Œsophagus
Pancreas
Colon and rectum
Breast (postmenopause)
Kidney
Gallblader
Endometrium
Ovary
Liver
Prostate (advanced cancer)
Hematological malignancies
Fruits and vegetables Mouth
Pharynx
Larynx
Œsophagus
Stomach
Lung (fruits)
Red  meat and processed meat Colon and rectum Dietary ﬁber Colon and rectum
Breast
Salt  and salted foods Stomach Dairy products Colon and rectum
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* Notably for smokers or asbestos-exposed subjects, and a dose >20 mg/d of beta
roducts (including milk) and 6 studies detailed results for milk
r cheese separately (Huncharek et al., 2008; Aune et al., 2012d;
in et al., 2007; Li et al., 2011b; Mao  et al., 2011; Lee et al., 2007b).
The association between colorectal cancer risk and milk intake
reviously judged as “probable” in the 2011 WCRF/AICR CUP report
WCRF/AICR, 2011) was conﬁrmed by one new meta-analysis of 9
rospective studies (Aune et al., 2012d) showing a decreased risk.
he association with total dairy products, not evaluated in the 2011
CRF/AICR CUP report (WCRF/AICR, 2011), is also considered as
probable” since the meta-analysis based on 10 prospective stud-
es (Aune et al., 2012d) also showed a decreased risk of colorectal
ancer. On the opposite, the meta-analysis of 7 prospective studies
ound no association between cheese intake and risk of colorectal
ancer, justifying to requalify the level of evidence from “sugges-
ive” to “not conclusive”.
The level of evidence previously judged as “suggestive” for
ncreased risk of prostate cancer associated with total dairy
roducts intake is conﬁrmed by the new meta-analyses of 11
rospective studies (Huncharek et al., 2008) and 13 prospective
tudies (Qin et al., 2007), respectively. The decreased risk of blad-
er cancer with the consumption of milk was previously evaluated
s “suggestive”. The association is conﬁrmed by one meta-analysis
6 prospective and 13 case-control studies combined or analyzed
eparately) (Mao  et al., 2011) but not by the other meta-analysis (5
rospective and 9 case-control studies) (Li et al., 2011b).
The decreased risk of breast cancer associated with total dairy
roducts intake observed in a new meta-analysis of 8 prospective
tudies (Dong et al., 2011) was considered as sufﬁcient to increase
he level of evidence from “not conclusive” (WCRF/AICR, 2010) to
suggestive”. The evidence for the association between kidney can-
er and total dairy products intake, for which no new study was
dentiﬁed, remains “not conclusive”.
Concerning cancer sites or subcategories of dairy products
hich were not previously evaluated by WCRF/AICR, the new
esults available did not allow to conclude. It concerned associa-
ions between the risk of bladder cancer and total dairy products
ntake (Li et al., 2011b) and between kidney (Lee et al., 2007b)
r prostate cancers (Huncharek et al., 2008; Qin et al., 2007) and
ilk consumption. Finally, there was no new published studyBreastfeeding Breast
ene.
concerning ovary, endometrium, pancreas, oesophagus, mouth, lar-
ynx, pharynx, lung, stomach, testis, lymphoma and skin cancers.
The level of evidence remains “not conclusive”.
Dairy products have the speciﬁcity to contain a variety of bioac-
tive compounds that could be related to positive or negative effects
on carcinogenesis in the same time. The main hypothesis under-
lying a possible protective effect of dairy products against cancer
risk relates to their calcium content and to a lesser extent vitamin
D, lactoferrin and fermentation products (Lamprecht and Lipkin,
2001; Norat and Riboli, 2003; Tsuda et al., 2010). A recent review
of the literature highlighted the ability of dairy products to modu-
late inﬂammatory processes (Bordoni et al., 2015). Milk is a source
of cholesterol and saturated fatty acids that might increase can-
cer risk; but it also contains conjugated linoleic, acid, sphingolipids
and butyric acid, which may  have hypolipidaemic and antioxi-
dant properties (Hague and Paraskeva, 1995; Parodi, 1997; Kelley
et al., 2007). Independently of its composition in carbohydrates and
lipids, milk consumed in high quantities increases blood levels of
IGF-1 which has been associated with an increased risk of breast
EHBC Collaborative Group et al. (2010) and prostate cancer (Chan
et al., 1998). Although the level of evidence of an increased risk
of prostate cancer is “suggestive” for total dairy products and “not
conclusive” for milk, suggested hypotheses concern a role of high
consumption of milk, via increased levels of androgens and oestro-
gens (Fleshner et al., 2004), presence of phytanic acid (Wright et al.,
2012) and high intake of proteins (Allen et al., 2008).
3.10. Breastfeeding
Epidemiological studies reporting on breastfeeding by the
mother and her risk of cancer either simply distinguish between
“ever”, exclusive or not, and “never”, or they measure lifetime dura-
tion of lactation.
The associations between breastfeeding and the risk of various
cancers have been evaluated by WCRF/AICR in 2007 and 2010–2014
CUP reports (WCRF/AICR, 2007, 2010, 2014a). Since the publication
of these reports, two  new meta-analyses (Anothaisintawee et al.,
2013; Luan et al., 2013) and one pooled analysis (Cronin-Fenton
et al., 2010) were identiﬁed (Appendix A, Part 2: Table 10). The
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Salt, sa lted 
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Beta -ca rotene 
suppl ements
* * *
*
‡
* * * * * ** ‡ * *
Physica l 
activity
*
C
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R
ec
tu
m
** ** * *
Fruits
Vegetables  
(non  starchy)
Dietary fib er **
Dairy produ cts * * **
Breastfee ding *
Con vincing Probab le Sug gesti ve
Non  
con clusive
Not stud ied Sug gesti ve Probab le Con vincing
Increa sed  can cer  risk Decrea sed  can cer risk
Fig. 2. Summary Table for levels of evidence between alcoholic beverages, obesity, physical activity and other nutritional factors and cancer risk.
* orts.
* orts.
‡ estos-
a
a
i
b
pLevel  of evidence was  newly studied since 2007 or 2010–2014 CUP WCRF/AICR rep
Level of evidence has been changed since 2007 or 2010–2014 CUP WCRF/AICR rep
Supplements containing high doses of beta-carotene, notably for smokers and asb
ssociations between breastfeeding and cancer of the breast, ovary,
nd adenocarcinoma of the oesophageal and gastric junction were
nvestigated.
The “convincing” level of evidence of the association between
reastfeeding and decreased risk of breast cancer in the WCRF/AICR
revious report (WCRF/AICR, 2010), is strengthened by the resultsexposed subjects.
of a recent meta-analysis including 69 observational studies
(Anothaisintawee et al., 2013).The level of evidence previously judged as “suggestive” for
decreased risk of ovarian cancer associated with breastfeeding,
is conﬁrmed by the recent results of a meta-analysis including 3
cohorts (Luan et al., 2013). A recent pooled analysis (Cronin-Fenton
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Fig. 3. From nutritional
t al., 2010) investigating the associations between breastfeed-
ng and oesophageal and gastric junction adenocarcinoma cancers,
hich were not previously evaluated by WCRF/AICR (WCRF/AICR,
007), observed signiﬁcant decreased risks. Considering the lim-
ted number of cases included, the level of evidence is considered
not conclusive”.
Several plausible mechanisms involved in lactation-induced
rotective effects have been identiﬁed: increased differentiation
f breast cells and lower exposure to sex hormones during amen-
rrhea, elimination of cells with DNA damage through strong
xfoliation of breast tissue and massive epithelial apoptosis during
r at the end of lactation (WCRF/AICR, 2010).
.11. Summary of the updated evidence
Fig. 2 gives an overview of all the levels of evidence updated
hrough the evaluation process. Based on this state of knowl-
dge, and the evidence graded as convincing or probable, the ten
utritional factors can be divided in two groups (Table 2): factors
hat increase the risk of cancer—alcoholic beverages, overweight
nd obesity, red and processed meat, salt and salted foods, and
eta-carotene supplements—and factors that decrease the risk of
ancer—physical activity, fruits and vegetables, dietary ﬁber, dairy
roducts, and breastfeeding. Although, no quantitative risk assess-
ent has been conducted, this information can be translated into
hree priority nutritional objectives for cancer prevention in the
eneral population (Fig. 3) (i) to reduce alcoholic beverages con-
umption, (ii) to have a balanced and diversiﬁed diet, (iii) to be
hysically active; and one objective directed to pregnant women:
o promote breastfeeding. Indeed, all objectives related to food fac-
ors that increase cancer risk (red meat and processed meat, salt
nd salted foods, and beta-carotene supplements) or to those that
ecrease cancer risk (fruits and vegetables, dietary ﬁber, dairy prod-
cts) can be aggregated in only one objective which is “to have a
alanced and diversiﬁed diet”. In addition, the reduction of over-
eight and obesity can be divided in two objectives “to have a
alanced and diversiﬁed diet” and “to be physically active”.OMEN)
s to priority objectives.
4. Discussion
Overall, in this evaluation nearly 150 relationships between the
alcoholic beverages, obesity, physical activity and the other nutri-
tional factors considered and the risk of cancer at various sites were
examined by the expert group. This work reinforces previous evi-
dence and also provides new information. Firstly, it establishes for
the ﬁrst time a level of evidence for cancer sites that were not
mentioned before, notably the evidence of the increased risk of
hematologic malignancies associated with overweight and obesity,
graded as “probable”. Secondly, it modiﬁes the level of evidence for
several associations, for instance the evidence of breast cancer risk
associated with dietary ﬁber, judged as “probable”. This evaluation
also highlights, for levels of evidence qualiﬁed as suggestive or not
conclusive which represent two thirds of all associations exam-
ined, that epidemiological and mechanistic research is still needed
to strengthen or refute them.
This updated state of knowledge enables to classify the nutri-
tional factors considered as either risk factors or protective factors
and to identify three priority objectives for nutritional cancer pre-
vention in the general population: to reduce alcoholic beverages
consumption, to have a balanced and diversiﬁed diet and to be
physically active. These priority objectives are pertinent in France
like in other developed countries (IARC, 2014b; Stein and Colditz,
2004).The report of the INCa expert group has been published in
French language in June 2015 (INCa, 2015b) and its main content is
now delivered to the general public, via the Internet and a leaﬂet,
in the framework of the French Cancer plan and National nutrition
and health program.
Since this evaluation, four WCRF/AICR CUP reports have
been published (WCRF/AICR, 2014b, 2015a,b,c). They focused on
prostate, liver, gallbladder and kidney cancers. Overall, their con-
clusions are in agreement with those of the INCa expert group, for
the associations between body fatness and increased risk of cancer
of the prostate (advanced cancer only), liver, gallbladder and kid-
ney. Regarding alcoholic beverages and liver cancer, the judgment
of the evidence in the CUP report is “convincing” whereas that of the
INCa expert group is “probable”. This discrepancy can be explained
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y some differences in the criteria that were met  in each evalua-
ion. In addition, the CUP report on kidney cancer concluded that
ess than 30 g/d alcohol consumption is associated with a decreased
isk of kidney cancer with an evidence judged as “probable”, and
hat beyond 30 g/d the level of evidence is insufﬁcient. However,
he mechanisms that might explain a decreased risk of kidney can-
er associated with alcohol remain unclear. This is the reason why
he INCa expert group considered the evidence as “not conclusive”.
urthermore, it must be recalled the importance of considering that
lcohol consumption is associated with increased risk of several
ther cancer sites with a convincing or probable level of evidence,
uch as the cancers of the mouth, pharynx, larynx, oesophagus,
iver, colon and rectum, and breast.
The International Agency for Research on Cancer (IARC) eval-
ates the carcinogenicity of various factors among which some
ifestyle factors. In a monography published in 2012, alcoholic bev-
rages, ethanol in alcoholic beverages and acetaldehyde associated
ith consumption of alcoholic beverages have been classiﬁed as
arcinogens to humans (Group 1) (IARC, 2012). In October 2015,
nother IARC monograph working group concluded that processed
eat is carcinogenic to humans (Group 1) and that red meat is
robably carcinogenic to humans (Group 2A) (Bouvard et al., 2015).
hese conclusions are consistent with our evaluations.
Recently, the fourth edition of the European code against can-
er has been published (Schuz et al., 2015). This initiative of the
uropean Commission aims to inform people about actions that
ay  help them to reduce their risk of cancer. This edition, which
as been coordinated by the IARC, consists of twelve recommen-
ations including nutritional recommendations. Recommendation
 is “Be physically active in everyday life. Limit the time you spend
itting.” Recommendation 5 is “Have a healthy diet: eat plenty of
hole grains, pulses, vegetables and fruits. Limit high-calorie foods
foods high in sugar or fat) and avoid sugary drinks. Avoid processed
eat; limit red meat and foods high in salt”. Recommendation 6 is
If you drink alcohol of any type, limit your intake. Not drinking
lcohol is better for cancer prevention.” Recommendation 10a for
omen is “Breastfeeding reduces the mother’s cancer risk. If you
an, breastfeed your baby”. Although the methods to evaluate the
iterature for alcohol drinking, diet, obesity/body fatness, physi-
al activity and breastfeeding in association with cancer, slightly
iffered according to factors (Scoccianti et al., 2015a; Norat et al.,
015; Anderson et al., 2015; Leitzmann et al., 2015; Scoccianti et al.,
015b) and with the method of the INCa expert group, the general
utritional recommendations of the European code are consistent
ith the conclusions and priority objectives that the INCa expert
roup has identiﬁed.
Finally, the overall impact of modiﬁcations of exposures to nutri-
ional factors on cancer incidence has been estimated: addressing
hese priority objectives based on nutritional factors might help
opulations of developed countries to reduce the burden of can-
er and avoid about 30% of the most frequent cancers (WCRF/AICR,
009; WCRF, 2015).
. Conclusions
This comprehensive review and evaluation of the current evi-
ence on 10 nutritional factors and the risk of more than 25 cancer
ites emphasizes three main objectives addressing alcohol con-
umption, diet and physical activity that should be attained to
mprove cancer prevention at the population and individual levels.
n the meantime, research effort must be maintained on numerous
ssociations whose evidence is still considered as “suggestive” or
ot “conclusive”.cology/Hematology 99 (2016) 308–323 319
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